Home
About Us
About Us
Board of Directors
Scientific Advisory Board
Management Team
Careers
For Researchers
Paxalisib
EVT801
Collaborating with Kazia
Publications and Presentations
For Partners
Our Current Partners
What We Are Looking For
For Patients
Accessing Kazia Drug Candidates in Clinical Trials
Accessing Kazia Drug Candidates for Compassionate Use
Resources for Patients
For Investors
ASX Announcements
SEC Filings
Corporate Presentations
Annual Reports
Financial Reports
AGM
Investor Newsletters
Corporate Governance
Shareholder Services
Media Centre
Overview
Latest News
Video
Coverage
Contact
Contact Us
Subscribe to email alerts
Heading &
Sub-heading can be edited through HQI
Home
>
For Investors
>
ASX Announcements
SEC Filings
Corporate Presentations
Annual Reports
Financial Reports
AGM
Investor Newsletters
Corporate Governance
Shareholder Services
EGM
Kazia Therapeutics Extraordinary General Meeting
Kazia Therapeutics will hold an EGM on Friday 24 February 2023 at 3pm
(AEDT)
at our offices at Level 24, Three International Towers, 300 Barangaroo Avenue, Sydney NSW 2000.
Notice of Meeting
View Report
The resolutions on the agenda for this Meeting cover the following:
Ratification of the prior issue of ATM Shares;
Ratification of the prior issue of Tranche 1 Placement Shares under Listing Rule 7.1
Ratification of the prior issue of Tranche 1 Placement Shares under Listing Rule 7.1A; and
Approval to issue Tranche 2 Placement Shares under Listing Rule 7.1
Email Alerts
For Investors
Contact Us
